GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Digital breast tomosythesis now makes up close to 50% of mammography systems in the U.S. "Tomo is going to replace just straight digital mammography simply because of the benefit of fewer recalls," explained Debra L. Monticciolo, MD.
Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.
"A significant part of burnout stems from the overwhelming administrative burden," explains Elizabeth Ann Ignacio, MD, FSIR, FACR, chair of the SIR Small and Rural Practices Committee.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Digital breast tomosythesis now makes up close to 50% of mammography systems in the U.S. "Tomo is going to replace just straight digital mammography simply because of the benefit of fewer recalls," explained Debra L. Monticciolo, MD.
Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.
"A significant part of burnout stems from the overwhelming administrative burden," explains Elizabeth Ann Ignacio, MD, FSIR, FACR, chair of the SIR Small and Rural Practices Committee.
Dana Smetherman, MD, CEO of the American College of Radiology, explains resources available through its Data Science Institute to evaluate and validate the quality of imaging algorithms.
Elizabeth Ann Ignacio, MD, FSIR, FACR, chair of SIR Small and Rural Practices Committee, and an ACR board member, outlines ways to make these positions outside of major cities more attractive.
Ron Blankstein, MD, director of cardiac computed tomography for Brigham and Women’s Hospital, details recent developments in cardiac MRI, nuclear imaging and CT.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.
